The price per bottle is $ 390 for developed countries and for American patients who are included in government health programs. Gilead also contacted generic drug manufacturers in India and Pakistan for the production and supply of remdesivir in 127 developing countries, with a selling price then ranging between $ 66.24 and $ 71.54.
Is the price justified
The price of remdesivir has been the subject of heated debate. Experts warn that Gilead should not appear to be taking advantage of the pandemic to make unwarranted profits. U.S. patient organizations say the drug should be cheaper because it was developed with financial support from the U.S. government.
Gilead says the price is justified because an early discharge saves about $ 12,000 per patient in the United States.